Cargando…
PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease
Presenilin-2 (PSEN2) mutation Thr421Met was identified from a 57-years old patient with early onset Alzheimer’s disease (EOAD) for the first time in Korea. Previously, this mutation was discovered in an EOAD patient in Japan without a change on amyloid production from the cellular study. Both Korean...
Autores principales: | Yang, YoungSoon, Bagyinszky, Eva, An, Seong Soo A., Kim, SangYun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656741/ https://www.ncbi.nlm.nih.gov/pubmed/36362122 http://dx.doi.org/10.3390/ijms232113331 |
Ejemplares similares
-
APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019) -
Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2020) -
Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2023) -
PSEN1 p.Thr116Ile Variant in Two Korean Families with Young Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2018) -
A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)